- Home
- VITL vs CERT Comparison
VITL vs CERT Comparison
Compare VITL & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VITL | CERT |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | United States | United States |
| Employees | N/A | 1576 |
| Industry | Packaged Foods | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 944.3M | 1.1B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | VITL | CERT |
|---|---|---|
| Price | $17.24 | $6.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 10 |
| Target Price | ★ $42.56 | $12.22 |
| AVG Volume (30 Days) | 2.2M | ★ 3.2M |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 22.03 | ★ 87.50 |
| EPS | ★ 1.44 | N/A |
| Revenue | ★ $759,444,000.00 | $418,838,000.00 |
| Revenue This Year | $22.76 | $5.05 |
| Revenue Next Year | $18.53 | $5.73 |
| P/E Ratio | $12.14 | ★ N/A |
| Revenue Growth | ★ 25.26 | 8.75 |
| 52 Week Low | $17.35 | $6.04 |
| 52 Week High | $53.13 | $15.38 |
Technical Indicators
Market Signals| Indicator | VITL | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 17.08 | 35.18 |
| Support Level | N/A | $6.04 |
| Resistance Level | $31.02 | $7.52 |
| Average True Range (ATR) | 1.09 | 0.41 |
| MACD | -0.37 | 0.05 |
| Stochastic Oscillator | 3.06 | 39.53 |
Price Performance
Historical ComparisonAbout VITL Vital Farms Inc.
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.